ID   ILKH_CAEEL              Unreviewed;       466 AA.
AC   Q9TZC4; Q9NG00;
DT   01-MAY-2000, integrated into UniProtKB/TrEMBL.
DT   01-MAY-2000, sequence version 1.
DT   22-JUL-2015, entry version 128.
DE   RecName: Full=Integrin-linked protein kinase homolog pat-4 {ECO:0000250|UniProtKB:Q13418};
DE            Short=ILK homolog {ECO:0000303|PubMed:12015115};
DE   AltName: Full=Paralyzed and arrested elongation at two-fold protein {ECO:0000303|PubMed:12015115};
GN   Name=pat-4 {ECO:0000312|WormBase:C29F9.7};
GN   ORFNames=C29F9.7 {ECO:0000312|WormBase:C29F9.7};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|EMBL:CAB77052.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10637513; DOI=10.1038/sj.onc.1203258;
RA   Lynch D.K., Ellis C.A., Edwards P.A., Hiles I.D.;
RT   "Integrin-linked kinase regulates phosphorylation of serine 473 of
RT   protein kinase B by an indirect mechanism.";
RL   Oncogene 18:8024-8032(1999).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH UNC-112 AND
RP   UNC-97, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLU-374.
RX   PubMed=12015115; DOI=10.1016/S0960-9822(02)00810-2;
RA   Mackinnon A.C., Qadota H., Norman K.R., Moerman D.G., Williams B.D.;
RT   "C. elegans PAT-4/ILK functions as an adaptor protein within integrin
RT   adhesion complexes.";
RL   Curr. Biol. 12:787-797(2002).
RN   [3] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4] {ECO:0000305}
RP   INTERACTION WITH PAT-6, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLU-374.
RX   PubMed=12781130; DOI=10.1016/S0960-9822(03)00372-5;
RA   Lin X., Qadota H., Moerman D.G., Williams B.D.;
RT   "C. elegans PAT-6/actopaxin plays a critical role in the assembly of
RT   integrin adhesion complexes in vivo.";
RL   Curr. Biol. 13:922-932(2003).
RN   [5] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16476426; DOI=10.1016/j.yexcr.2006.01.006;
RA   Xu X., Rongali S.C., Miles J.P., Lee K.D., Lee M.;
RT   "pat-4/ILK and unc-112/Mig-2 are required for gonad function in
RT   Caenorhabditis elegans.";
RL   Exp. Cell Res. 312:1475-1483(2006).
RN   [6] {ECO:0000305}
RP   INTERACTION WITH UNC-97, AND SUBCELLULAR LOCATION.
RX   PubMed=17662976; DOI=10.1016/j.ydbio.2007.06.014;
RA   Norman K.R., Cordes S., Qadota H., Rahmani P., Moerman D.G.;
RT   "UNC-97/PINCH is involved in the assembly of integrin cell adhesion
RT   complexes in Caenorhabditis elegans body wall muscle.";
RL   Dev. Biol. 309:45-55(2007).
RN   [7] {ECO:0000305}
RP   DISRUPTION PHENOTYPE.
RX   PubMed=22761445; DOI=10.1074/jbc.M112.354852;
RA   Qadota H., Moerman D.G., Benian G.M.;
RT   "A molecular mechanism for the requirement of PAT-4 (integrin-linked
RT   kinase (ILK)) for the localization of UNC-112 (Kindlin) to integrin
RT   adhesion sites.";
RL   J. Biol. Chem. 287:28537-28551(2012).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24314125; DOI=10.1111/acel.12189;
RA   Kumsta C., Ching T.T., Nishimura M., Davis A.E., Gelino S.,
RA   Catan H.H., Yu X., Chu C.C., Ong B., Panowski S.H., Baird N.,
RA   Bodmer R., Hsu A.L., Hansen M.;
RT   "Integrin-linked kinase modulates longevity and thermotolerance in C.
RT   elegans through neuronal control of HSF-1.";
RL   Aging Cell 13:419-430(2014).
RN   [9] {ECO:0000305}
RP   INTERACTION WITH UNC-112, AND MUTAGENESIS OF PRO-257.
RX   PubMed=24692564; DOI=10.1074/jbc.M114.556308;
RA   Qadota H., Luo Y., Matsunaga Y., Park A.S., Gernert K.M., Benian G.M.;
RT   "Suppressor mutations suggest a surface on PAT-4 (Integrin-linked
RT   Kinase) that interacts with UNC-112 (Kindlin).";
RL   J. Biol. Chem. 289:14252-14262(2014).
CC   -!- FUNCTION: Probable pseudokinase that acts as an adapter protein.
CC       Involved in the assembly of dense bodies and M lines during body
CC       wall muscle development by recruiting several of their components
CC       to integrin-mediated attachment sites (PubMed:12015115). Plays a
CC       role in distal tip cell (DTC) migration and in oocyte development
CC       probably by regulating the actin cytoskeleton (PubMed:16476426).
CC       May be involved in thermotolereance and lifespan
CC       (PubMed:24314125). {ECO:0000269|PubMed:12015115,
CC       ECO:0000269|PubMed:16476426, ECO:0000269|PubMed:24314125}.
CC   -!- SUBUNIT: Interacts (via protein kinase domain) with unc-112 (via
CC       N-terminus) (PubMed:12015115, PubMed:24692564). Interacts (via ANK
CC       repeats) with unc-97 (via first LIM domain) (PubMed:12015115,
CC       PubMed:17662976). Interacts (via protein kinase domain) with pat-6
CC       (via C-terminus CH domain) (PubMed:12781130). May form a complex
CC       with unc-112, unc-97 and pat-6 (PubMed:12781130, PubMed:17662976,
CC       PubMed:24692564). Does not interact with integrin pat-3
CC       (PubMed:12015115). {ECO:0000269|PubMed:12015115,
CC       ECO:0000269|PubMed:12781130, ECO:0000269|PubMed:17662976,
CC       ECO:0000269|PubMed:24692564}.
CC   -!- INTERACTION:
CC       O16785:pat-6; NbExp=4; IntAct=EBI-1564527, EBI-328106;
CC       Q18685:unc-112; NbExp=5; IntAct=EBI-1564527, EBI-1564809;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, M line
CC       {ECO:0000269|PubMed:12015115}. Basal cell membrane
CC       {ECO:0000269|PubMed:12015115, ECO:0000269|PubMed:17662976};
CC       Peripheral membrane protein {ECO:0000269|PubMed:12015115,
CC       ECO:0000269|PubMed:24314125}. Note=Co-localizes in dense bodies
CC       and M lines with integrin pat-3. Localization to muscle attachment
CC       sites is regulated by pat-2, unc-52 and unc-112 (PubMed:12015115).
CC       Co-localizes with pat-3 and pat-6 at body wall muscle attachment
CC       sites (PubMed:12781130, PubMed:17662976).
CC       {ECO:0000269|PubMed:12015115, ECO:0000269|PubMed:12781130,
CC       ECO:0000269|PubMed:17662976}.
CC   -!- TISSUE SPECIFICITY: Expressed in body wall muscle.
CC       {ECO:0000269|PubMed:12015115}.
CC   -!- DEVELOPMENTAL STAGE: Expression starts in body wall muscle at the
CC       1.5-fold embryonic stage. {ECO:0000269|PubMed:12015115}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- DISRUPTION PHENOTYPE: Embryonic lethality due to 1.5 fold stage-
CC       onset paralysis. Mutant embryos have defects in maintaining
CC       polarization of several components involved in the assembly of
CC       dense bodies and M lines, such as integrin pat-3, unc-89 and unc-
CC       112 to muscle attachment sites (PubMed:12015115). RNAi-mediated
CC       knockdown causes sterility resulting from oocyte accumulation in
CC       the proximal gonad and distal tip cell (DTC) migration defects (33
CC       percent of animals). Actin cytoskeleton in the proximal gonad
CC       appears disorganized (PubMed:16476426). RNAi-mediated knockdown in
CC       hatched embryos but not in adults causes adult-onset paralysis
CC       characterized by the collapse of myosin filaments in body wall
CC       muscles and a decrease in pharyngeal pumping (PubMed:24314125). In
CC       L1 larval stage, results in the formation of large myosin
CC       aggregates in body wall muscle cells (PubMed:22761445). In adults,
CC       causes an increase in lifespan, resistance to heat stress and
CC       increased expression of stress response factors hsf-1, sod-3, hsp-
CC       16.2 and gst-4 (PubMed:24314125). {ECO:0000269|PubMed:12015115,
CC       ECO:0000269|PubMed:16476426, ECO:0000269|PubMed:22761445,
CC       ECO:0000269|PubMed:24314125}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 3 ANK repeats.
CC       {ECO:0000255|RuleBase:RU003321}.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
DR   EMBL; AJ249344; CAB77052.1; -; mRNA.
DR   EMBL; BX284603; CCD66066.1; -; Genomic_DNA.
DR   PIR; T33574; T33574.
DR   RefSeq; NP_497139.1; NM_064738.5.
DR   UniGene; Cel.10243; -.
DR   ProteinModelPortal; Q9TZC4; -.
DR   SMR; Q9TZC4; 20-465.
DR   IntAct; Q9TZC4; 4.
DR   STRING; 6239.C29F9.7; -.
DR   PaxDb; Q9NG00; -.
DR   PRIDE; Q9TZC4; -.
DR   EnsemblMetazoa; C29F9.7; C29F9.7; WBGene00003931.
DR   GeneID; 175175; -.
DR   KEGG; cel:CELE_C29F9.7; -.
DR   UCSC; C29F9.7; c. elegans.
DR   CTD; 175175; -.
DR   WormBase; C29F9.7; CE19706; WBGene00003931; pat-4.
DR   eggNOG; COG0666; -.
DR   GeneTree; ENSGT00760000118807; -.
DR   HOGENOM; HOG000047828; -.
DR   InParanoid; Q9TZC4; -.
DR   KO; K06272; -.
DR   OMA; RDFNEEH; -.
DR   OrthoDB; EOG7T1RB0; -.
DR   PhylomeDB; Q9TZC4; -.
DR   Reactome; REACT_277854; Cell-extracellular matrix interactions.
DR   Reactome; REACT_284269; Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
DR   NextBio; 887074; -.
DR   PRO; PR:Q9TZC4; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   ExpressionAtlas; Q9TZC4; baseline and differential.
DR   GO; GO:0005912; C:adherens junction; IDA:WormBase.
DR   GO; GO:0008305; C:integrin complex; IDA:WormBase.
DR   GO; GO:0031430; C:M band; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005178; F:integrin binding; TAS:WormBase.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:WormBase.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:WormBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IGI:WormBase.
DR   GO; GO:0030239; P:myofibril assembly; IMP:WormBase.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:WormBase.
DR   GO; GO:0009966; P:regulation of signal transduction; IEA:InterPro.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Cell adhesion; Cell membrane; Complete proteome;
KW   Cytoplasm; Membrane; Reference proteome; Repeat.
FT   CHAIN         1    466       Integrin-linked protein kinase homolog
FT                                pat-4. {ECO:0000305}.
FT   REPEAT       50     79       ANK 1. {ECO:0000255}.
FT   REPEAT       83    112       ANK 2. {ECO:0000255}.
FT   REPEAT      116    145       ANK 3. {ECO:0000255}.
FT   DOMAIN      210    465       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MUTAGEN     257    257       P->L: Restores the interaction with unc-
FT                                112 when mutated at "Asp-382" and the
FT                                localization of mutated unc-112 to
FT                                integrin adhesion sites in body wall
FT                                muscles. {ECO:0000269|PubMed:24692564}.
FT   MUTAGEN     374    374       E->K: No effect on the interaction with
FT                                unc-112 or pat-6.
FT                                {ECO:0000269|PubMed:12015115,
FT                                ECO:0000269|PubMed:12781130}.
FT   CONFLICT      1     17       Missing (in Ref. 1; CAB77052).
FT                                {ECO:0000305}.
**
**   #################    INTERNAL SECTION    ##################
**EV ECO:0000250; UniProtKB:Q13418; ROZ; 13-JUL-2015.
**EV ECO:0000255; -; ROZ; 13-JUL-2015.
**EV ECO:0000255; PROSITE-ProRule:PRU00159; ROZ; 13-JUL-2015.
**EV ECO:0000255; RuleBase:RU003321; ROZ; 13-JUL-2015.
**EV ECO:0000269; PubMed:12015115; ROZ; 13-JUL-2015.
**EV ECO:0000269; PubMed:12781130; ROZ; 14-JUL-2015.
**EV ECO:0000269; PubMed:16476426; ROZ; 13-JUL-2015.
**EV ECO:0000269; PubMed:17662976; ROZ; 14-JUL-2015.
**EV ECO:0000269; PubMed:22761445; ROZ; 14-JUL-2015.
**EV ECO:0000269; PubMed:24314125; ROZ; 14-JUL-2015.
**EV ECO:0000269; PubMed:24692564; ROZ; 14-JUL-2015.
**EV ECO:0000303; PubMed:12015115; ROZ; 13-JUL-2015.
**EV ECO:0000305; -; ROZ; 14-JUL-2015.
**EV ECO:0000312; EMBL:CAB77052.1; ROZ; 13-JUL-2015.
**EV ECO:0000312; Proteomes:UP000001940; ROZ; 13-JUL-2015.
**EV ECO:0000312; WormBase:C29F9.7; ROZ; 13-JUL-2015.
**ZA ROZ, 13-JUL-2015;
**ZZ Merged with 1 TrEMBL entry.
**ZZ Related to Swiss-Prot entries in rzILKb.log.
**ZZ PMID:12015115 mentionned the localization of pat-4 in other tissues
**ZZ besides body wall muscle but the data are not shown therefore they
**ZZ were not included in the annotation.
**ZZ In PMID:24692564, several residues have been mutated but the
**ZZ experimental data is not shown therefore they were not included in the
**ZZ annotation.
**ZZ The comment "The protein kinase domain is predicted to be
**ZZ catalytically inactive" has been added to CC DOMAIN instead of a CC
**ZZ CAUTION. This is being discuss to decide where this kind of comment
**ZZ should go.
**ZZ PMID:8106547 was not used as shows similar data regarding body wall
**ZZ muscle defects.
**ZZ Some references mentionned the possible presence of a PH domain at the
**ZZ N-terminus of the kinase domain as there is no experimental evidence
**ZZ and Anabelle didn't detect it it was not added.
SQ   SEQUENCE   466 AA;  52260 MW;  0D13147657A0DF11 CRC64;
     MSLSTHYHAH KPNVPIIMED VFGWVREGNA FQVRVWLDDH EHDLNVGDDH AFSLLHWAAK
     GGHVAIAEML LSRGARVNST NMGDDTSLHL AAAHGHRQIV VKLLSRKADV NATNEHGMTP
     LHYACFWGYE QIAEDLISCG AAVNVCNKKG MTPLDVCQPM CKNTILEIAQ EHGQSPNDRV
     PFKDTTWKGT KSRTRDATLS RYTGVDVSSL NLITKIAESH SGELWRGKWQ GNDIVARILN
     VQEVTARISR DFQTEFPALR IFAHPNICAV LAAANQPPNL VIISQYMPFG SLYNVLHEQS
     SVVIDHGQAV RFALDIARGM SYLHSLDPML LRFYLSSKHV VVDEELTAKL SMADTKFSFQ
     EVGKAYSPAW MSPEALSRAP EDLNIRAADM WSFAILLWEL NTREVPFSDL PPMECGMKIA
     LEGLRVHIPP GIARNMNRLM NICMNEDPGR RPNFDQIIPI LERMIL
//
ID   UNC97_CAEEL             Reviewed;         348 AA.
AC   P50464;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   29-APR-2015, entry version 113.
DE   RecName: Full=LIM domain-containing protein unc-97;
DE   AltName: Full=PINCH homolog;
DE   AltName: Full=Uncoordinated protein 97;
GN   Name=unc-97; ORFNames=F14D12.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Bristol N2;
RX   PubMed=9885243; DOI=10.1083/jcb.144.1.45;
RA   Hobert O., Moerman D.G., Clark K.A., Beckerle M.C., Ruvkun G.;
RT   "A conserved LIM protein that affects muscular adherens junction
RT   integrity and mechanosensory function in Caenorhabditis elegans.";
RL   J. Cell Biol. 144:45-57(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   INTERACTION WITH UNC-98.
RX   PubMed=12808046; DOI=10.1091/mbc.E02-10-0676;
RA   Mercer K.B., Flaherty D.B., Miller R.K., Qadota H., Tinley T.L.,
RA   Moerman D.G., Benian G.M.;
RT   "Caenorhabditis elegans UNC-98, a C2H2 Zn finger protein, is a novel
RT   partner of UNC-97/PINCH in muscle adhesion complexes.";
RL   Mol. Biol. Cell 14:2492-2507(2003).
RN   [4]
RP   FUNCTION, INTERACTION WITH PAT-4, SUBCELLULAR LOCATION, LIM DOMAIN,
RP   AND DISRUPTION PHENOTYPE.
RX   PubMed=17662976; DOI=10.1016/j.ydbio.2007.06.014;
RA   Norman K.R., Cordes S., Qadota H., Rahmani P., Moerman D.G.;
RT   "UNC-97/PINCH is involved in the assembly of integrin cell adhesion
RT   complexes in Caenorhabditis elegans body wall muscle.";
RL   Dev. Biol. 309:45-55(2007).
CC   -!- FUNCTION: Involved in maintaining the integrity of integrin-
CC       mediated adhesion structures such as dense bodies and M lines and
CC       thereby of the myofilament lattice during body wall muscle
CC       development (PubMed:9885243, PubMed:17662976). Contributes to the
CC       mechanosensory functions of touch neurons (PubMed:9885243).
CC       {ECO:0000269|PubMed:17662976, ECO:0000269|PubMed:9885243}.
CC   -!- SUBUNIT: Interacts with unc-98 (PubMed:12808046). Interacts (via
CC       LIM domain 1) with pat-4 (via ANK repeats); the interaction with
CC       pat-4 promotes the formation of a complex composed of unc-112 and
CC       pat-6 (PubMed:17662976). {ECO:0000269|PubMed:12808046,
CC       ECO:0000269|PubMed:17662976}.
CC   -!- INTERACTION:
CC       Q09497:rsu-1; NbExp=5; IntAct=EBI-319593, EBI-319599;
CC   -!- SUBCELLULAR LOCATION: Basal cell membrane
CC       {ECO:0000269|PubMed:17662976}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17662976}. Cell junction, adherens junction
CC       {ECO:0000269|PubMed:9885243}. Cytoplasm, myofibril, sarcomere, M
CC       line {ECO:0000269|PubMed:17662976}. Nucleus
CC       {ECO:0000269|PubMed:17662976, ECO:0000269|PubMed:9885243}.
CC       Note=Localizes in dense bodies which are similar to mammalian Z-
CC       lines. Localization to the body wall muscle cell membrane is
CC       regulated by pat-3 and pat-4. {ECO:0000269|PubMed:17662976}.
CC   -!- TISSUE SPECIFICITY: Restricted to tissue types that attach to the
CC       hypodermis, specifically body wall muscles, vulval muscles, and
CC       mechanosensory neurons. {ECO:0000269|PubMed:9885243}.
CC   -!- DOMAIN: LIM domain 1 is important for basal cell membrane
CC       localization. LIM domain 2 and 3 are important for nuclear
CC       localization. {ECO:0000269|PubMed:17662976}.
CC   -!- DISRUPTION PHENOTYPE: Onset paralysis at the 1.5-fold embryonic
CC       stage characterized by the absence of body wall muscle contraction
CC       and the failure to elongate beyond the 2-fold stage. At the basal
CC       membrane of embryonic body wall muscle cells, the formation of
CC       mature myosin and actin filaments and the organization of integrin
CC       pat-3 into punctate linear arrays are defective. Normal pharyngeal
CC       muscle contraction. {ECO:0000269|PubMed:17662976}.
CC   -!- SIMILARITY: Contains 5 LIM zinc-binding domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00125}.
DR   EMBL; AF035583; AAD09435.1; -; mRNA.
DR   EMBL; FO080820; CCD83467.1; -; Genomic_DNA.
DR   PIR; T16076; T16076.
DR   RefSeq; NP_508943.3; NM_076542.5.
DR   UniGene; Cel.19566; -.
DR   ProteinModelPortal; P50464; -.
DR   SMR; P50464; 14-317.
DR   BioGrid; 45760; 8.
DR   DIP; DIP-24818N; -.
DR   IntAct; P50464; 5.
DR   MINT; MINT-1050203; -.
DR   STRING; 6239.F14D12.2.1; -.
DR   PaxDb; P50464; -.
DR   EnsemblMetazoa; F14D12.2.1; F14D12.2.1; WBGene00006826.
DR   EnsemblMetazoa; F14D12.2.2; F14D12.2.2; WBGene00006826.
DR   GeneID; 180827; -.
DR   KEGG; cel:CELE_F14D12.2; -.
DR   UCSC; F14D12.2.1; c. elegans.
DR   CTD; 180827; -.
DR   WormBase; F14D12.2; CE04392; WBGene00006826; unc-97.
DR   eggNOG; NOG263350; -.
DR   GeneTree; ENSGT00760000118910; -.
DR   HOGENOM; HOG000253950; -.
DR   InParanoid; P50464; -.
DR   OMA; NQNRALC; -.
DR   OrthoDB; EOG7GBFX3; -.
DR   PhylomeDB; P50464; -.
DR   NextBio; 911142; -.
DR   PRO; PR:P50464; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   GO; GO:0005912; C:adherens junction; IDA:WormBase.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:WormBase.
DR   GO; GO:0031430; C:M band; IDA:WormBase.
DR   GO; GO:0005654; C:nucleoplasm; IDA:WormBase.
DR   GO; GO:0005634; C:nucleus; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0017022; F:myosin binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0045216; P:cell-cell junction organization; IMP:WormBase.
DR   GO; GO:0007517; P:muscle organ development; IMP:WormBase.
DR   GO; GO:0050954; P:sensory perception of mechanical stimulus; IMP:WormBase.
DR   Gene3D; 2.10.110.10; -; 5.
DR   InterPro; IPR017351; PINCH.
DR   InterPro; IPR001781; Znf_LIM.
DR   PANTHER; PTHR24210; PTHR24210; 1.
DR   Pfam; PF00412; LIM; 5.
DR   PIRSF; PIRSF038003; PINCH; 1.
DR   SMART; SM00132; LIM; 5.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 4.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 5.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell junction; Cell membrane; Complete proteome;
KW   Cytoplasm; LIM domain; Membrane; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Zinc.
FT   CHAIN         1    348       LIM domain-containing protein unc-97.
FT                                /FTId=PRO_0000075909.
FT   DOMAIN       21     73       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       82    132       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      146    196       LIM zinc-binding 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      205    255       LIM zinc-binding 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      264    315       LIM zinc-binding 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
**
**   #################    INTERNAL SECTION    ##################
**EV ECO:0000255; PROSITE-ProRule:PRU00125; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:12808046; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:17662976; ROZ; 14-JUL-2015.
**EV ECO:0000269; PubMed:9885243; ROZ; 15-JUL-2015.
**ZB SYP, 18-DEC-2003; ROZ, 17-JUL-2015;
SQ   SEQUENCE   348 AA;  40308 MW;  0CD22C39628ECEDA CRC64;
     MDSDHNHING DLAHGFENMV CVRCNDGFSM QDQMVNSSGQ VWHSECFVCA QCFEPFPDGI
     YFEYEGRKYC EHDFHVLFSP CCGKCNEFIV GRVIKAMNAS WHPGCFCCEI CNKQLADVGF
     LRNAGRALCR ECNEREKAAG HGRYVCHKCH AMIDDGQHIK FRGDSFHPYH FKCKRCNNEL
     TTASREVNGE LYCLRCHDTM GIPICGACHR PIEERVIAAL GKHWHVEHFV CSVCEKPFLG
     HRHYERKGLP YCEQHFHKLF GNLCFKCGDP CCGEVFQALQ KTWCVKCFSC SFCDKKLDQK
     TKFYEFDMKP TCKRCYDRFP TELKKRISES LKDRDVENQR RSMSPGPK
//
ID   UNC52_CAEEL             Reviewed;        3375 AA.
AC   Q06561; O18261; O18263; Q6BEQ6; Q9U7E8; Q9XTD2; Q9XTI5;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   16-SEP-2015, entry version 146.
DE   RecName: Full=Basement membrane proteoglycan;
DE   AltName: Full=Perlecan homolog;
DE   AltName: Full=Uncoordinated protein 52;
DE            Short=Protein unc-52;
DE   Flags: Precursor;
GN   Name=unc-52; ORFNames=ZC101.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A), AND FUNCTION.
RX   PubMed=8393416; DOI=10.1101/gad.7.8.1471;
RA   Rogalski T.M., Williams B.D., Mullen G.P., Moerman D.G.;
RT   "Products of the unc-52 gene in Caenorhabditis elegans are homologous
RT   to the core protein of the mammalian basement membrane heparan sulfate
RT   proteoglycan.";
RL   Genes Dev. 7:1471-1484(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2451-3375 (ISOFORMS C/E).
RC   STRAIN=Bristol N2;
RX   PubMed=10512861; DOI=10.1091/mbc.10.10.3205;
RA   Mullen G.P., Rogalski T.M., Bush J.A., Gorji P.R., Moerman D.G.;
RT   "Complex patterns of alternative splicing mediate the spatial and
RT   temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans.";
RL   Mol. Biol. Cell 10:3205-3221(1999).
RN   [4]
RP   FUNCTION.
RX   PubMed=12015115; DOI=10.1016/S0960-9822(02)00810-2;
RA   Mackinnon A.C., Qadota H., Norman K.R., Moerman D.G., Williams B.D.;
RT   "C. elegans PAT-4/ILK functions as an adaptor protein within integrin
RT   adhesion complexes.";
RL   Curr. Biol. 12:787-797(2002).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1422, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=12754521; DOI=10.1038/nbt829;
RA   Kaji H., Saito H., Yamauchi Y., Shinkawa T., Taoka M., Hirabayashi J.,
RA   Kasai K., Takahashi N., Isobe T.;
RT   "Lectin affinity capture, isotope-coded tagging and mass spectrometry
RT   to identify N-linked glycoproteins.";
RL   Nat. Biotechnol. 21:667-672(2003).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1422, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Probable role in myofilament assembly and/or attachment
CC       of the myofilament lattice to the cell membrane. May be an
CC       extracellular anchor for integrin receptors in muscle
CC       (PubMed:8393416). Involved in pat-4 polarization and recruitment
CC       to nascent muscle attachment sites (PubMed:12015115).
CC       {ECO:0000269|PubMed:12015115, ECO:0000269|PubMed:8393416}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix, basement membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=e;
CC         IsoId=Q06561-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=a;
CC         IsoId=Q06561-2; Sequence=VSP_007195, VSP_007196;
CC       Name=b;
CC         IsoId=Q06561-3; Sequence=VSP_007191, VSP_007192;
CC         Note=No experimental confirmation available.;
CC       Name=c;
CC         IsoId=Q06561-4; Sequence=VSP_007193, VSP_007194, VSP_007195,
CC                                  VSP_007196;
CC         Note=No experimental confirmation available.;
CC       Name=f;
CC         IsoId=Q06561-5; Sequence=VSP_020104, VSP_007195, VSP_020105;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Found in the basement membrane of all
CC       contractile tissues. It is concentrated over muscle dense bodies
CC       and M-lines which are associated with beta-integrin.
CC   -!- DEVELOPMENTAL STAGE: Synthesized early in embryogenesis.
CC   -!- SIMILARITY: Contains 17 Ig-like C2-type (immunoglobulin-like)
CC       domains. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 7 laminin EGF-like domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00460}.
CC   -!- SIMILARITY: Contains 3 laminin G-like domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00122}.
CC   -!- SIMILARITY: Contains 2 laminin IV type A domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00458}.
CC   -!- SIMILARITY: Contains 3 LDL-receptor class A domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00124}.
DR   EMBL; L13458; AAA28156.1; -; Genomic_DNA.
DR   EMBL; Z93395; CAB07704.1; -; Genomic_DNA.
DR   EMBL; Z93395; CAB07706.1; -; Genomic_DNA.
DR   EMBL; Z93375; CAB07706.1; JOINED; Genomic_DNA.
DR   EMBL; Z93395; CAB07707.1; -; Genomic_DNA.
DR   EMBL; Z93375; CAB07707.1; JOINED; Genomic_DNA.
DR   EMBL; Z93395; CAB07708.1; -; Genomic_DNA.
DR   EMBL; Z93375; CAB07708.1; JOINED; Genomic_DNA.
DR   EMBL; Z93395; CAH04744.1; -; Genomic_DNA.
DR   EMBL; Z93375; CAH04744.1; JOINED; Genomic_DNA.
DR   EMBL; AF132883; AAD25092.1; -; mRNA.
DR   PIR; C88369; C88369.
DR   PIR; F88369; F88369.
DR   PIR; T19821; T19821.
DR   RefSeq; NP_001022488.1; NM_001027317.5.
DR   RefSeq; NP_497044.3; NM_064643.8. [Q06561-1]
DR   RefSeq; NP_497045.1; NM_064644.3. [Q06561-4]
DR   RefSeq; NP_497046.1; NM_064645.4. [Q06561-2]
DR   RefSeq; NP_497047.1; NM_064646.4. [Q06561-3]
DR   UniGene; Cel.13832; -.
DR   ProteinModelPortal; Q06561; -.
DR   SMR; Q06561; 190-221.
DR   BioGrid; 40407; 13.
DR   IntAct; Q06561; 1.
DR   STRING; 6239.ZC101.2e; -.
DR   PaxDb; Q06561; -.
DR   PRIDE; Q06561; -.
DR   EnsemblMetazoa; ZC101.2e; ZC101.2e; WBGene00006787. [Q06561-1]
DR   GeneID; 175126; -.
DR   KEGG; cel:CELE_ZC101.2; -.
DR   UCSC; ZC101.2e; c. elegans. [Q06561-1]
DR   CTD; 175126; -.
DR   WormBase; ZC101.2a; CE15028; WBGene00006787; unc-52.
DR   WormBase; ZC101.2b; CE15030; WBGene00006787; unc-52.
DR   WormBase; ZC101.2c; CE15034; WBGene00006787; unc-52.
DR   WormBase; ZC101.2e; CE18424; WBGene00006787; unc-52.
DR   WormBase; ZC101.2f; CE37074; WBGene00006787; unc-52.
DR   eggNOG; NOG258321; -.
DR   GeneTree; ENSGT00530000063501; -.
DR   InParanoid; Q06561; -.
DR   OMA; RQCTSSS; -.
DR   PhylomeDB; Q06561; -.
DR   NextBio; 886870; -.
DR   PRO; PR:Q06561; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   ExpressionAtlas; Q06561; baseline and differential.
DR   GO; GO:0005604; C:basement membrane; IDA:WormBase.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IMP:WormBase.
DR   GO; GO:0016477; P:cell migration; IGI:WormBase.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IGI:WormBase.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:WormBase.
DR   GO; GO:0031581; P:hemidesmosome assembly; IGI:WormBase.
DR   GO; GO:0040011; P:locomotion; IMP:WormBase.
DR   GO; GO:0007517; P:muscle organ development; IMP:WormBase.
DR   GO; GO:0048644; P:muscle organ morphogenesis; IGI:WormBase.
DR   GO; GO:0030239; P:myofibril assembly; IEP:UniProtKB.
DR   GO; GO:0040017; P:positive regulation of locomotion; IMP:WormBase.
DR   Gene3D; 2.60.120.200; -; 3.
DR   Gene3D; 2.60.40.10; -; 17.
DR   Gene3D; 4.10.400.10; -; 3.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR009030; Growth_fac_rcpt_N_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR002049; Laminin_EGF.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR000034; Laminin_IV.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   Pfam; PF07679; I-set; 5.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF00052; Laminin_B; 2.
DR   Pfam; PF00053; Laminin_EGF; 7.
DR   Pfam; PF02210; Laminin_G_2; 3.
DR   Pfam; PF00057; Ldl_recept_a; 3.
DR   PRINTS; PR00261; LDLRECEPTOR.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00180; EGF_Lam; 5.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 12.
DR   SMART; SM00281; LamB; 2.
DR   SMART; SM00282; LamG; 3.
DR   SMART; SM00192; LDLa; 3.
DR   SUPFAM; SSF48726; SSF48726; 16.
DR   SUPFAM; SSF49899; SSF49899; 3.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   SUPFAM; SSF57424; SSF57424; 3.
DR   PROSITE; PS00022; EGF_1; 7.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50026; EGF_3; 3.
DR   PROSITE; PS01248; EGF_LAM_1; 7.
DR   PROSITE; PS50027; EGF_LAM_2; 5.
DR   PROSITE; PS50835; IG_LIKE; 17.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 3.
DR   PROSITE; PS51115; LAMININ_IVA; 2.
DR   PROSITE; PS01209; LDLRA_1; 3.
DR   PROSITE; PS50068; LDLRA_2; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Basement membrane; Complete proteome;
KW   Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Immunoglobulin domain; Laminin EGF-like domain; Proteoglycan;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   3375       Basement membrane proteoglycan.
FT                                /FTId=PRO_0000026698.
FT   DOMAIN       45    130       Ig-like C2-type 1.
FT   DOMAIN      148    184       LDL-receptor class A 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      189    225       LDL-receptor class A 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      232    269       LDL-receptor class A 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      271    355       Ig-like C2-type 2.
FT   DOMAIN      384    431       Laminin EGF-like 1; truncated.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00460}.
FT   DOMAIN      432    441       Laminin EGF-like 2; first part.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00460}.
FT   DOMAIN      450    633       Laminin IV type A 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00458}.
FT   DOMAIN      634    666       Laminin EGF-like 2; second part.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00460}.
FT   DOMAIN      674    720       Laminin EGF-like 3; truncated.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00460}.
FT   DOMAIN      721    730       Laminin EGF-like 4; first part.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00460}.
FT   DOMAIN      740    921       Laminin IV type A 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00458}.
FT   DOMAIN      922    954       Laminin EGF-like 4; second part.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00460}.
FT   DOMAIN      955   1004       Laminin EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00460}.
FT   DOMAIN     1011   1060       Laminin EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00460}.
FT   DOMAIN     1061   1111       Laminin EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00460}.
FT   DOMAIN     1126   1222       Ig-like C2-type 3.
FT   DOMAIN     1226   1311       Ig-like C2-type 4.
FT   DOMAIN     1319   1401       Ig-like C2-type 5.
FT   DOMAIN     1410   1499       Ig-like C2-type 6.
FT   DOMAIN     1503   1585       Ig-like C2-type 7.
FT   DOMAIN     1588   1680       Ig-like C2-type 8.
FT   DOMAIN     1690   1785       Ig-like C2-type 9.
FT   DOMAIN     1793   1878       Ig-like C2-type 10.
FT   DOMAIN     1886   1970       Ig-like C2-type 11.
FT   DOMAIN     1973   2069       Ig-like C2-type 12.
FT   DOMAIN     2073   2163       Ig-like C2-type 13.
FT   DOMAIN     2173   2260       Ig-like C2-type 14.
FT   DOMAIN     2263   2343       Ig-like C2-type 15.
FT   DOMAIN     2349   2435       Ig-like C2-type 16.
FT   DOMAIN     2446   2530       Ig-like C2-type 17.
FT   DOMAIN     2532   2713       Laminin G-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   DOMAIN     2793   2960       Laminin G-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   DOMAIN     3180   3359       Laminin G-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   COMPBIAS   2961   3093       Glu-rich.
FT   COMPBIAS   2972   3066       Thr-rich.
FT   CARBOHYD   1422   1422       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:12754521,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD   2476   2476       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2950   2950       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   3143   3143       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   3156   3156       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID     66    114       {ECO:0000250}.
FT   DISULFID    149    161       {ECO:0000250}.
FT   DISULFID    156    174       {ECO:0000250}.
FT   DISULFID    168    183       {ECO:0000250}.
FT   DISULFID    190    202       {ECO:0000250}.
FT   DISULFID    197    215       {ECO:0000250}.
FT   DISULFID    209    224       {ECO:0000250}.
FT   DISULFID    233    246       {ECO:0000250}.
FT   DISULFID    240    259       {ECO:0000250}.
FT   DISULFID    253    268       {ECO:0000250}.
FT   DISULFID    384    400       {ECO:0000250}.
FT   DISULFID    402    411       {ECO:0000250}.
FT   DISULFID    414    429       {ECO:0000250}.
FT   DISULFID    634    648       {ECO:0000250}.
FT   DISULFID    636    689       {ECO:0000250}.
FT   DISULFID    691    700       {ECO:0000250}.
FT   DISULFID    703    718       {ECO:0000250}.
FT   DISULFID    955    964       {ECO:0000250}.
FT   DISULFID    957    971       {ECO:0000250}.
FT   DISULFID    974    983       {ECO:0000250}.
FT   DISULFID    986   1002       {ECO:0000250}.
FT   DISULFID   1011   1021       {ECO:0000250}.
FT   DISULFID   1013   1027       {ECO:0000250}.
FT   DISULFID   1030   1039       {ECO:0000250}.
FT   DISULFID   1042   1058       {ECO:0000250}.
FT   DISULFID   1061   1069       {ECO:0000250}.
FT   DISULFID   1063   1079       {ECO:0000250}.
FT   DISULFID   1082   1091       {ECO:0000250}.
FT   DISULFID   1094   1109       {ECO:0000250}.
FT   DISULFID   1152   1200       {ECO:0000250}.
FT   DISULFID   1338   1384       {ECO:0000250}.
FT   DISULFID   1435   1481       {ECO:0000250}.
FT   DISULFID   1527   1573       {ECO:0000250}.
FT   DISULFID   1618   1663       {ECO:0000250}.
FT   DISULFID   1719   1767       {ECO:0000250}.
FT   DISULFID   1814   1861       {ECO:0000250}.
FT   DISULFID   1907   1954       {ECO:0000250}.
FT   DISULFID   1998   2053       {ECO:0000250}.
FT   DISULFID   2099   2147       {ECO:0000250}.
FT   DISULFID   2195   2242       {ECO:0000250}.
FT   DISULFID   2284   2329       {ECO:0000250}.
FT   DISULFID   2374   2420       {ECO:0000250}.
FT   DISULFID   2467   2514       {ECO:0000250}.
FT   DISULFID   2713   2725       {ECO:0000250}.
FT   DISULFID   2719   2736       {ECO:0000250}.
FT   DISULFID   2738   2747       {ECO:0000250}.
FT   DISULFID   2754   2764       {ECO:0000250}.
FT   DISULFID   2759   2773       {ECO:0000250}.
FT   DISULFID   2775   2784       {ECO:0000250}.
FT   DISULFID   2935   2960       {ECO:0000250}.
FT   DISULFID   3141   3152       {ECO:0000250}.
FT   DISULFID   3146   3162       {ECO:0000250}.
FT   DISULFID   3164   3173       {ECO:0000250}.
FT   DISULFID   3333   3359       {ECO:0000250}.
FT   VAR_SEQ    1129   1222       VLRVRIMEPKRQIALPGDRVHWICQVTGYTTEKIHVEWTKV
FT                                GEMSLPPNAKAYDGYLVLKGVEAENAGQYRCTATTITQYAT
FT                                DDALLTISKRIS -> G (in isoform f).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_020104.
FT   VAR_SEQ    1129   1160       VLRVRIMEPKRQIALPGDRVHWICQVTGYTTE -> GDFAR
FT                                NSPSQNSSGQRRHRRRRIRVRSRFYHH (in isoform
FT                                b). {ECO:0000305}.
FT                                /FTId=VSP_007191.
FT   VAR_SEQ    1161   3375       Missing (in isoform b). {ECO:0000305}.
FT                                /FTId=VSP_007192.
FT   VAR_SEQ    1695   1695       R -> H (in isoform c). {ECO:0000305}.
FT                                /FTId=VSP_007193.
FT   VAR_SEQ    1696   1882       Missing (in isoform c). {ECO:0000305}.
FT                                /FTId=VSP_007194.
FT   VAR_SEQ    2442   2482       QDQVTFTVADSLPVVYTVGQPAYLSCIGKTETKPNQSVVWT
FT                                -> RKRKHLGNRRGRRLRHRRRNAQNGPLSRKTRTTTKLFG
FT                                SWF (in isoform a, isoform c and isoform
FT                                f). {ECO:0000305}.
FT                                /FTId=VSP_007195.
FT   VAR_SEQ    2483   3375       Missing (in isoform a and isoform c).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_007196.
FT   VAR_SEQ    2485   3375       Missing (in isoform f). {ECO:0000305}.
FT                                /FTId=VSP_020105.
FT   CONFLICT    512    512       Missing (in Ref. 1; AAA28156).
FT                                {ECO:0000305}.
FT   CONFLICT    547    547       R -> P (in Ref. 1; AAA28156).
FT                                {ECO:0000305}.
**
**   #################    INTERNAL SECTION    ##################
**EV ECO:0000250; -; XXX; 01-JAN-1900.
**EV ECO:0000255; -; XXX; 01-JAN-1900.
**EV ECO:0000255; PROSITE-ProRule:PRU00122; XXX; 01-JAN-1900.
**EV ECO:0000255; PROSITE-ProRule:PRU00124; XXX; 01-JAN-1900.
**EV ECO:0000255; PROSITE-ProRule:PRU00458; XXX; 01-JAN-1900.
**EV ECO:0000255; PROSITE-ProRule:PRU00460; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:12015115; ROZ; 13-JUL-2015.
**EV ECO:0000269; PubMed:12754521; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:17761667; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:8393416; XXX; 01-JAN-1900.
**EV ECO:0000305; -; XXX; 01-JAN-1900.
**IS Q06561-6
**ZB ELW, 07-APR-2003; ALG/LYG, 14-AUG-2006; ELW, 14-AUG-2006; LYG, 30-APR-2008;
**ZB REF, 12-MAY-2008; BEC, 05-DEC-2012; REH, 14-JUN-2013; ROZ, 17-JUL-2015;
SQ   SEQUENCE   3375 AA;  369052 MW;  1AA418BB4E5D67AA CRC64;
     MKRSSTVLAA LLALLLVATN DAARHRKYRQ TYQDIDSDDD DTSDVQITVF PSEKEVRDGR
     DVSFECRART SDNSVYPTVR WARVGGPLPS SAHDSGGRLT INPVQLSDAG TYICVSDYNG
     NTVEARATLS VVSYGPQEVS NGLRQAGQCM ADEKACGNNE CVKNDYVCDG EPDCRDRSDE
     ANCPAISRTC EPNEFKCNNN KCVQKMWLCD GDDDCGDNSD ELNCNAKPSS SDCKPTEFQC
     HDRRQCVPSS FHCDGTNDCH DGSDEVGCVQ PTVVDPPQTN LQVPRGTTFS LTCKAVAVPE
     PYINWRLNWG PVCEPPRCLQ TSEGGYGTLT IHDAQPVDQG AYTCEAINVK GRVLATPDCI
     VRVVDDPRPQ PPQPPTAPPQ RASCDTRGAV TPYPNNYGTC ECKSQVTGPN CDQCKPGAFH
     LSEKSPEGCL KCFCFGVSND CRSSGHYRTK DRLMFAGDAE GVTISDIEER TIDRNTPFSF
     FKTGYLTFDG TTDGVAKYWR LPQRFLGDKV TAYGGKMEFE IEFSGSGHHS SEPMVVLKGN
     QNILVHRVRN QEHVLRSDSP VRITVETYET NYEQLNGAAA TREDLLMVLA DLDAFLIRAT
     HVAHQTSTSL GDVSWEIAVD RYTPDGLALE VEQCVCPPGY LGTSCEDCAP GYERSGYGPY
     LGTCVPIQPR HQQCGPGAVA PTAPAQGQCQ CKASVIGPNC DRCAPNSFGL APTNPQGCIP
     CFCSGVTQQC SASSYRRTSV SIDYARGDRD QLELTTSDSR QPYSPQTRAE LSGQAIEFRS
     FEEARGQTLY WKLPEKFLGD KVTSYGGTLE YTFKFSGNGN SDQSADVILR GNDIALQYKH
     REPFYADREN KVQIKIIETS WQRVDGQQAT REHLLMTLAD LDTLLIKSTY NDDCTDSQLL
     SANLEFAEPY GQGLTAAEVE QCICPPGYVG TSCEDCAPGY SRTGGGLYLG LCEKCECNGH
     ASQCDKEYGY CLDCQHNTEG DQCERCKPGF VGDARRGTPN DCQPEATRAP CHCNNHSPRG
     CDSFGRCLLC EHNTEGTHCE RCKKGYYGDA TKGSPYDCTP CPCPGASDCY LDNEGQVACR
     ICPAGLQGRL CNECAPGYTR SNKPAGRVCE PIGQVTNEDI TFVQKPHEVL RVRIMEPKRQ
     IALPGDRVHW ICQVTGYTTE KIHVEWTKVG EMSLPPNAKA YDGYLVLKGV EAENAGQYRC
     TATTITQYAT DDALLTISKR ISGRPPQPVI DPPHLVVNEG EPAAFRCWVP GIPDCQITWH
     REQLGGPLPH GVYQTGNALK IPQSQLHHAG RYICSAANQY GTGQSPPAVL EVKKPVIPPK
     VDPIRQTVDR DQPARFKCWV PGNSNVQLRW SRPGGAPLPS GVQEQQGILH IPRASDQEVG
     QYVCTATDPS DNTPLQSEPV QLNIRDPAPP QRGAAPQIDP PNQTVNVNDP AQFRCWVPGQ
     PRAQLKWSRK DGRPLPNGIL ERDGFLRIDK SQLHDAGEYE CTSTEPDGST QLSPPARLNV
     NQPQAIQPQV DPPVQTVNEG EPSRIRCWVP GHPNIQLQFV KRGRRPLPAH ARFSQGNLEI
     PRTLKSDEDE YICIATDPTT NRPVESNPAR VIVKSPIRPI IDPAEQTVPE GSPFKIRCYV
     PGHPSVQLTF RRVSGQLNED ADENNGLLAV QRAELTDEGD YICTARDPDT GAPIDSTPAT
     VHVTNAAAPP QVEARPPQHP VITPQTQTIP EGDPARIQCT VPGNPSAAQH LSFERVDGKG
     LPFGSSDDRG VLTIPSTQLQ DAGEYVCLYS PENSPPVKTN PSTLNVTPEG TPPRPVATPP
     LLSVAPGSPA RFNCVAHSDT PARIRWGFRE ENGPLPEHVN QDGDDIVISE AGDRNVGEYV
     CSATNDFGTG VADPVRLEVT EDQEPPTAVV EPRTWNGKPG ERHQFRCITT GSPTPKITWT
     GPNGSPLPHD VTPLEPNILD FSNGRSELNG DYTCTASNPI GEASDHGNVN IGPSLTVKTN
     PPGPKLIVTV GEPLQVKCEA FGAPGDPEPE VEWLHDPGPE RGDLPDDFKP VTISEQFIRH
     PNVGLGNAGV YTCKGSSAHA TATKNIYIEV VEPSRIATVS ILGGSSQWFD QGEKGELICT
     ATGSSLVDRL EWEKVDDQLP TDVEEHNEPG LLHFPSFKNS YAGEYRCNGY RNNEIIASAA
     VHVHSSANAD DEPKVEIEPP RVRVVSQGDN IVLKCSVQGA ENGEHFKWAL LRGGSLVRQL
     GTEPTLEITK ADPSNDFGVY RCNVEDNNGL VIGSAFTAVS VGQQDKSHAQ IVKFDDKSDA
     SFTCPIYSVP GSKVDWTYEN GDLPSKAVPN GNKIEIKEFD DASAGTYVCK VSFDGNVVEG
     FVTAQMFVPD TIIQVLLEVS SESPQIGDRA WFDCKVTGDP SAVISWTKEG NDDLPPNAQV
     TGGRLLFTDL KEDNAGVYRC VAKTKAGPLQ TRTVLNVGSG KQDQVTFTVA DSLPVVYTVG
     QPAYLSCIGK TETKPNQSVV WTKEEGDLPS GSRVEQGVLM LPSVHRDDEG SYTCEIVKEE
     NPVFSTVDLQ IDDFIPVIDG EPIELPPLSD EEIVNLDIEI TLNTANPKGI IFETKRINSG
     DLLATPYDTI HHEAKITDYG TVLYEFDIGN GRQIVETTNP INPNEWNVIK IKNDKNQVTI
     QLNDESATIR QHTNPLPSLS TGVNRPVFIG GRHEPTNEAN DFRGIISQVV LSGHNVGLGD
     ARIPSSVVKY DACASTNLCL NGANCRNANN HHGFSCECAE EFHGEYCQWR SNSCHDESCN
     TGICLDNEES WQCVCPLGTT GLRCEEKTEI PQPLGFTSDT SFLAVKRPVK FESIKMKLRP
     QADSDEHILM YFASDYGSNT KQYTSLSLIA NQVVLTVRRP DKEVQKIRSE TLEAGELIDV
     AVRQAGNALV MTVDGNQVST IETDTLKPGT EIFIGGLPPG LNSPDDVVEQ SFQGCVYEIL
     INSQDVDLQN LSSSGDISSC EESQFPVEED DTTTTTTTEE PEAVIEEPTT EEPTTTEEPI
     TEEPTEEPTT TEEPTTTEEP TTTTEEPTTT TTEEPYHIYE TSRDDDPEII IPVETTTTST
     TTTSTTEEPE AEPALVLPTD PVEENDVSDE EEEISTISTV SPDNGLDSDS DYSEGTLPPD
     SSSEEIVVGD VYSTQEPNNI CANSTCGMNG QCVPRNMTHY TCECKLYYDG PTCSLFKPIE
     HAARFDGDAF IELSSDEFPH LTSEKDEIVA FKFKTEQQNG VLLWQGQRPT VQQMEDYISV
     GIVNGHLHFS YELGGGAAHL ISEERVDDGK EHSVRFERKG REGQMRIDNY REVDGRSTGI
     LAMLNVDGNI FVGGVPDISK ATGGLFSNNF VGCIADVELN GVKLDLMATA IDGKNVKPCD
     EWMHRKRWLY RRRVR
//
ID   UN112_CAEEL             Reviewed;         720 AA.
AC   Q18685;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   16-SEP-2015, entry version 112.
DE   RecName: Full=Protein unc-112;
DE   AltName: Full=Mitogen-inducible mig-2 protein-like;
DE   AltName: Full=Uncoordinated protein 112;
GN   Name=unc-112; ORFNames=C47E8.7;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF THR-85.
RX   PubMed=10893272; DOI=10.1083/jcb.150.1.253;
RA   Rogalski T.M., Mullen G.P., Gilbert M.M., Williams B.D., Moerman D.G.;
RT   "The UNC-112 gene in Caenorhabditis elegans encodes a novel component
RT   of cell-matrix adhesion structures required for integrin localization
RT   in the muscle cell membrane.";
RL   J. Cell Biol. 150:253-264(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   INTERACTION WITH PAT-4, AND SUBCELLULAR LOCATION.
RX   PubMed=12015115; DOI=10.1016/S0960-9822(02)00810-2;
RA   Mackinnon A.C., Qadota H., Norman K.R., Moerman D.G., Williams B.D.;
RT   "C. elegans PAT-4/ILK functions as an adaptor protein within integrin
RT   adhesion complexes.";
RL   Curr. Biol. 12:787-797(2002).
RN   [4]
RP   SUBUNIT OF A COMPLEX WITH PAT-4 AND PAT-6.
RX   PubMed=12781130; DOI=10.1016/S0960-9822(03)00372-5;
RA   Lin X., Qadota H., Moerman D.G., Williams B.D.;
RT   "C. elegans PAT-6/actopaxin plays a critical role in the assembly of
RT   integrin adhesion complexes in vivo.";
RL   Curr. Biol. 13:922-932(2003).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16476426; DOI=10.1016/j.yexcr.2006.01.006;
RA   Xu X., Rongali S.C., Miles J.P., Lee K.D., Lee M.;
RT   "pat-4/ILK and unc-112/Mig-2 are required for gonad function in
RT   Caenorhabditis elegans.";
RL   Exp. Cell Res. 312:1475-1483(2006).
RN   [6]
RP   FUNCTION, INTERACTION WITH PAT-4 AND PAT-3, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF THR-346; GLU-349 AND ASP-382.
RX   PubMed=22761445; DOI=10.1074/jbc.M112.354852;
RA   Qadota H., Moerman D.G., Benian G.M.;
RT   "A molecular mechanism for the requirement of PAT-4 (integrin-linked
RT   kinase (ILK)) for the localization of UNC-112 (Kindlin) to integrin
RT   adhesion sites.";
RL   J. Biol. Chem. 287:28537-28551(2012).
CC   -!- FUNCTION: Probable regulator of cell-extracellular matrix
CC       adhesion. Required during initial muscle assembly to form dense
CC       bodies and M-lines (PubMed:10893272, PubMed:22761445). Plays a
CC       role in distal tip cell (DTC) migration and in oocyte development
CC       probably by regulating the actin cytoskeleton (PubMed:16476426).
CC       {ECO:0000269|PubMed:10893272, ECO:0000269|PubMed:16476426,
CC       ECO:0000269|PubMed:22761445}.
CC   -!- SUBUNIT: Interacts with integrin pat-3 (via cytoplasmic tail)
CC       (PubMed:12015115). Interacts (via N-terminus) with pat-4/ILK (via
CC       protein kinase domain); the interaction is required to promote the
CC       binding to pat-3 (PubMed:12015115, PubMed:12781130,
CC       PubMed:22761445). Probably forms a complex with pat-4 and pat-6
CC       (PubMed:12781130). {ECO:0000269|PubMed:12015115,
CC       ECO:0000269|PubMed:12781130, ECO:0000269|PubMed:22761445}.
CC   -!- INTERACTION:
CC       Q9TZC4:pat-4; NbExp=5; IntAct=EBI-1564809, EBI-1564527;
CC   -!- SUBCELLULAR LOCATION: Basal cell membrane
CC       {ECO:0000269|PubMed:10893272, ECO:0000269|PubMed:22761445};
CC       Peripheral membrane protein {ECO:0000269|PubMed:10893272,
CC       ECO:0000269|PubMed:22761445}. Cytoplasm, myofibril, sarcomere, M
CC       line {ECO:0000269|PubMed:22761445}. Note=Colocalizes with pat-
CC       3/beta-integrin in dense bodies and M-lines in body wall muscles.
CC       Requires unc-52/perlecan, pat-3 and pat-4 to be localized to the
CC       muscle cell membrane. {ECO:0000269|PubMed:10893272,
CC       ECO:0000269|PubMed:12015115, ECO:0000269|PubMed:22761445}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in muscle cells in both
CC       embryos and adults.
CC   -!- DOMAIN: The FERM domain is not correctly detected by PROSITE or
CC       Pfam techniques because it contains the insertion of a PH domain.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown causes sterility
CC       resulting from oocyte accumulation in the proximal gonad and
CC       distal tip cell (DTC) migration defects (19 percent of animals).
CC       Actin cytoskeleton in the proximal gonad appears disorganized.
CC       {ECO:0000269|PubMed:16476426}.
CC   -!- SIMILARITY: Belongs to the kindlin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 FERM domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 PH domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00145}.
DR   EMBL; AF217185; AAF20162.1; -; mRNA.
DR   EMBL; Z75530; CAA99790.1; -; Genomic_DNA.
DR   PIR; T20016; T20016.
DR   RefSeq; NP_506628.1; NM_074227.6.
DR   UniGene; Cel.5462; -.
DR   ProteinModelPortal; Q18685; -.
DR   SMR; Q18685; 12-91, 277-530, 538-694.
DR   IntAct; Q18685; 2.
DR   STRING; 6239.C47E8.7.2; -.
DR   PaxDb; Q18685; -.
DR   EnsemblMetazoa; C47E8.7.1; C47E8.7.1; WBGene00006836.
DR   EnsemblMetazoa; C47E8.7.2; C47E8.7.2; WBGene00006836.
DR   GeneID; 179972; -.
DR   KEGG; cel:CELE_C47E8.7; -.
DR   UCSC; C47E8.7.1; c. elegans.
DR   CTD; 179972; -.
DR   WormBase; C47E8.7; CE05443; WBGene00006836; unc-112.
DR   eggNOG; NOG238024; -.
DR   GeneTree; ENSGT00390000013444; -.
DR   HOGENOM; HOG000231715; -.
DR   InParanoid; Q18685; -.
DR   KO; K17083; -.
DR   OMA; HKDARIQ; -.
DR   PhylomeDB; Q18685; -.
DR   NextBio; 907602; -.
DR   PRO; PR:Q18685; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   GO; GO:0030055; C:cell-substrate junction; IDA:WormBase.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031430; C:M band; IDA:WormBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IMP:WormBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB.
DR   GO; GO:0040011; P:locomotion; IMP:WormBase.
DR   GO; GO:0007517; P:muscle organ development; IDA:UniProtKB.
DR   GO; GO:1901074; P:regulation of engulfment of apoptotic cell; IMP:WormBase.
DR   Gene3D; 1.20.80.10; -; 2.
DR   Gene3D; 2.30.29.30; -; 2.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR011993; PH/PTB_dom.
DR   InterPro; IPR001849; PH_domain.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF00169; PH; 1.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF47031; SSF47031; 2.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Complete proteome; Cytoplasm; Membrane;
KW   Reference proteome.
FT   CHAIN         1    720       Protein unc-112.
FT                                /FTId=PRO_0000219458.
FT   DOMAIN      288    614       FERM.
FT   DOMAIN      402    507       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   MUTAGEN      85     85       T->I: In R367; induces disorganized body
FT                                wall muscle and paralyzed as adults.
FT                                {ECO:0000269|PubMed:10893272}.
FT   MUTAGEN     346    346       T->A: Loss of the interaction between C-
FT                                and N-terminus but no effect on the
FT                                interaction with pat-4 and pat-3. Normal
FT                                localization to integrin-adhesion
FT                                complexes in body wall muscle cells. Loss
FT                                of interaction with pat-4 but normal
FT                                localization to integrin-adhesion
FT                                complexes; when associated with V-382.
FT                                {ECO:0000269|PubMed:22761445}.
FT   MUTAGEN     349    349       E->K: Loss of the interaction between C-
FT                                and N-terminus but no effect on the
FT                                interaction with pat-4 and pat-3. Normal
FT                                localization to integrin-adhesion
FT                                complexes in body wall muscle cells. Loss
FT                                of interaction with pat-4 but normal
FT                                localization to integrin-adhesion
FT                                complexes; when associated with V-382.
FT                                {ECO:0000269|PubMed:22761445}.
FT   MUTAGEN     382    382       D->V: Loss of interaction with pat-4 but
FT                                not with pat-3. Fails to localize to
FT                                integrin-adhesion complexes in body wall
FT                                muscle cells. Loss of interaction with
FT                                pat-4 but normal localization to
FT                                integrin-adhesion complexes; when
FT                                associated with A-346 or K-349.
FT                                {ECO:0000269|PubMed:22761445}.
**
**   #################    INTERNAL SECTION    ##################
**DR PROSITE; PS00661; FERM_2; FALSE_NEG.
**DR PROSITE; PS50057; FERM_3; FALSE_NEG.
**EV ECO:0000255; PROSITE-ProRule:PRU00145; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:10893272; ROZ; 14-JUL-2015.
**EV ECO:0000269; PubMed:12015115; ROZ; 14-JUL-2015.
**EV ECO:0000269; PubMed:12781130; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:16476426; ROZ; 13-JUL-2015.
**EV ECO:0000269; PubMed:22761445; ROZ; 14-JUL-2015.
**EV ECO:0000305; -; XXX; 01-JAN-1900.
**ZA SYP, 05-DEC-2003;
**ZB ELW, 14-AUG-2006; ROZ, 17-JUL-2015;
SQ   SEQUENCE   720 AA;  82355 MW;  663CB0E9891C1A12 CRC64;
     MAHLVEGTSI IDGKWQLPIL VTDLNIQRSI SVLGNLNVGG LMLELVSECD VERDWSDHAL
     WWPEKRRWLQ HTRSTLDQNG ITAETQLEFT PMHKEARIQL PDMQMIDARV DFSVNSFKAT
     KKLCRDLGIR YSEELSLKRY IPPEDLRRGT SDADNMNGPL SMRPGEESVG PMTLRKAAPI
     FASQSNLDMR RRGQSPALSQ SGHIFNAHEM GTLPRHGTLP RGVSPSPGAY NDTMRRTPIM
     PSISFSEGLE NEQFDDALIH SPRLAPSRDT PVFRPQNYVE KAAINRGWLD SSRSLMEQGI
     FEGDIILLRF KFMNFFDLNP KYDPVRINQL YEQAKWSILL DEFDHTEEEA TLFAALQLQA
     TLQRDSPEPE ENNKDDVDIL LDELEQNLDA AALNRRSDLT QVPELADYLK YMKPKKLAAF
     KGFKRAFFSF RDLYLSYHQS SSDVNSAPLG HFSLKGCEVS QDVSVGQQKY HIKLLLPTAE
     GMIDFILKCD SEHQYARWMA ACRLASRGKS MADSSYQQEV ESIKNLLKMQ SGNGNENGNS
     NTASRKAAAV KLPNDFNVDE YISSKYVRRA RSKQQIQQRV SDAHGNVRQL TATEAKLQYI
     RAWQALPEHG IHYFIVRFRN ARKAELVAVA VNRLAKLNMD NGESLKTWRF ANMKKWHVNW
     EIRHLKIQFE DEDIEFKPLS ADCKVVHEFI GGYIFLSMRS KEHSQNLDEE LFHKLTGGWA
//
ID   PAT2_CAEBR              Reviewed;        1224 AA.
AC   A8X3A7;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   07-JAN-2015, entry version 39.
DE   RecName: Full=Integrin alpha pat-2 {ECO:0000250|UniProtKB:P34446};
DE   AltName: Full=Paralyzed arrest at two-fold protein 2;
DE   Flags: Precursor;
GN   Name=pat-2 {ECO:0000312|EMBL:CAP27117.2}; ORFNames=CBG06891;
OS   Caenorhabditis briggsae.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6238;
RN   [1] {ECO:0000312|EMBL:CAP27117.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AF16 {ECO:0000312|EMBL:CAP27117.2};
RX   PubMed=14624247; DOI=10.1371/journal.pbio.0000045;
RA   Stein L.D., Bao Z., Blasiar D., Blumenthal T., Brent M.R., Chen N.,
RA   Chinwalla A., Clarke L., Clee C., Coghlan A., Coulson A.,
RA   D'Eustachio P., Fitch D.H.A., Fulton L.A., Fulton R.E.,
RA   Griffiths-Jones S., Harris T.W., Hillier L.W., Kamath R.,
RA   Kuwabara P.E., Mardis E.R., Marra M.A., Miner T.L., Minx P.,
RA   Mullikin J.C., Plumb R.W., Rogers J., Schein J.E., Sohrmann M.,
RA   Spieth J., Stajich J.E., Wei C., Willey D., Wilson R.K., Durbin R.M.,
RA   Waterston R.H.;
RT   "The genome sequence of Caenorhabditis briggsae: a platform for
RT   comparative genomics.";
RL   PLoS Biol. 1:166-192(2003).
CC   -!- FUNCTION: Integrin that may have a role in cell motility and in
CC       cell-cell interactions. Required for distal tip cell migration and
CC       dorsal pathfinding. Involved in pat-4 polarization and recruitment
CC       to nascent muscle attachment. {ECO:0000250|UniProtKB:P34446}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha pat-2
CC       associates with beta pat-3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q3UV74};
CC       Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q3UV74}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000255}.
CC   -!- SIMILARITY: Contains 7 FG-GAP repeats. {ECO:0000255}.
DR   EMBL; HE601347; CAP27117.2; -; Genomic_DNA.
DR   STRING; 6238.CBG06891; -.
DR   EnsemblMetazoa; CBG06891; CBG06891; CBG06891.
DR   WormBase; CBG06891; CBP34898; WBGene00029084; Cbr-pat-2.
DR   eggNOG; NOG26407; -.
DR   HOGENOM; HOG000115457; -.
DR   InParanoid; A8X3A7; -.
DR   OMA; NRWNMAN; -.
DR   OrthoDB; EOG71ZP14; -.
DR   Proteomes; UP000008549; Chromosome III.
DR   Proteomes; UP000008549; Unassembled WGS sequence.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   3: Inferred from homology;
KW   Cell adhesion; Complete proteome; Glycoprotein; Integrin; Membrane;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28   1224       Integrin alpha pat-2. {ECO:0000255}.
FT                                /FTId=PRO_0000370206.
FT   TOPO_DOM     28   1153       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1154   1174       Helical. {ECO:0000255}.
FT   TOPO_DOM   1175   1224       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       29     96       FG-GAP 1.
FT   REPEAT      110    173       FG-GAP 2.
FT   REPEAT      180    235       FG-GAP 3.
FT   REPEAT      236    292       FG-GAP 4.
FT   REPEAT      293    347       FG-GAP 5.
FT   REPEAT      364    423       FG-GAP 6.
FT   REPEAT      427    490       FG-GAP 7.
FT   MOTIF       622    624       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD     74     74       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    230    230       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    610    610       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    681    681       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    775    775       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    819    819       N-linked (GlcNAc...). {ECO:0000255}.
**
**   #################    INTERNAL SECTION    ##################
**ET Evidence tagged version exists.
**EV ECO:0000250; -; XXX; 01-JAN-1900.
**EV ECO:0000250; UniProtKB:P34446; DJL; 24-FEB-2009.
**EV ECO:0000250; UniProtKB:Q3UV74; DJL; 13-MAR-2009.
**EV ECO:0000255; -; DJL; 24-FEB-2009.
**EV ECO:0000312; EMBL:CAP27117.2; ZZZ; 11-NOV-2008.
**ZA DJL, 24-FEB-2009;
**ZB DJL, 29-MAR-2012; ELS, 11-APR-2012; ROZ, 17-JUL-2015;
SQ   SEQUENCE   1224 AA;  135935 MW;  8F75B2BB878FB360 CRC64;
     MREGSFPRRT RLLCLLAAVV LISTVTSFNI DTKNVVLHHM ANNYFGYSLD FYNEQKGMPV
     LVVGAPEAET TNPNLSGIRR PGAVYACSVN RPTCREVHVD KMKGNLKKLN GSHLVPIEDK
     AYQFFGATVK SNDKHDKLLM CAPKYKYFYS KFEVIEPVGT CFYAENGFEK TEEFSSCKQE
     PARHGRHRLG YGQCGFSGAI PGKKNQDRVF LGAPGVWYWQ GAIFSQNTKN QTDRPNTEYG
     SKEYDHDMMG YATATGDFDG DGIDDIVAGV PRGNDLHGKL VLYTSKLKMM INLTDEVSTQ
     HGQYCGGALA VADVNKDGRD DIIMGCPFYT DYGSVKDAKT QERKPQYDVG KVIVFLQTAP
     GVFGKQLAVV GDDQWGRFGH SLAAAGDLNL DGYNDVIVGA PYAGKNKQGA VYVIHGSKDG
     VREKPTQKIE ASQIGHGTAR AFGFAVAGGV DVDGNGMPDI AVGAWKSGNA AVLLTKPVVT
     VTGATEPESA LINVEEKNCD VDGKLGKQAC RHINTCFKYE GKGDTPNDLE FDLRFNLDDH
     SPEPRAYFLQ KDVKSDRSIK VASGSKTRDH PSSIEQRVRL EKGRQKCFRH RFFASSTMKD
     KLSPIHWSVN YTYVESKSGK LRGDKLEPAI DTTVPLSFQN KINIANNCGK DDLCVPDLKV
     TAVADREKFL LGTQDNTMLI NVTVQNGGED SYETKLYFDV PQGFEYGGIE SVGADGSAPA
     CSPTSDEPDS DGKWTFACDL GNPLPANKVV SSVVRVTASS DKPPLAPISI NAHVNSSNDE
     EAHTIADNKV TFTIPVDFKN QLSLNGRSNP EQVDFSMTNK TRSDVFDDNE IGPVVSHLYQ
     ISNRGPSEID AATLDIFWPS FSTEGGHLLY IITEPVVNPP NKGRCRVKQL QNVNPLNLRI
     TNEHVPTEPP VAKTPNEYSR EEDDESYEDE TTTQSQTHHQ TRTEHTQHHQ GPVHVYERDE
     DKIRQNTGNW QYVEDKKKKG DYEYIPDDQE YDGDDFEDDD EDFDRAGSKR VKRAPVPKKK
     KKEGSRSGEP RSDKARFSDL REAVKLSKEA GGVVDYKGPL SRASVDCNGL RCTHIECDIY
     DLKEDEFVLV EIFSRLYTNT LVDERNPGGD ISSLALARVT STKYNWPHKP TLITAVSTNM
     NAIASEEGRD LPWWLYLLAI LIGLAILILL ILLLWRCGFF KRNRPPTEHA ELRAEKQPAA
     HYADTQSRYA PQDQYSQGRH GQML
//
ID   PAT2_CAEEL              Reviewed;        1226 AA.
AC   P34446;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   16-SEP-2015, entry version 124.
DE   RecName: Full=Integrin alpha pat-2;
DE   AltName: Full=Paralyzed arrest at two-fold protein 2;
DE   Flags: Precursor;
GN   Name=pat-2; ORFNames=F54F2.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=8106547; DOI=10.1083/jcb.124.4.475;
RA   Williams B.D., Waterston R.H.;
RT   "Genes critical for muscle development and function in Caenorhabditis
RT   elegans identified through lethal mutations.";
RL   J. Cell Biol. 124:475-490(1994).
RN   [4]
RP   FUNCTION.
RX   PubMed=12015115; DOI=10.1016/S0960-9822(02)00810-2;
RA   Mackinnon A.C., Qadota H., Norman K.R., Moerman D.G., Williams B.D.;
RT   "C. elegans PAT-4/ILK functions as an adaptor protein within integrin
RT   adhesion complexes.";
RL   Curr. Biol. 12:787-797(2002).
RN   [5]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=12915588; DOI=10.1242/jcs.00705;
RA   Cram E.J., Clark S.G., Schwarzbauer J.E.;
RT   "Talin loss-of-function uncovers roles in cell contractility and
RT   migration in C. elegans.";
RL   J. Cell Sci. 116:3871-3878(2003).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-108; ASN-228; ASN-290;
RP   ASN-608 AND ASN-819, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15888633; DOI=10.1093/glycob/cwi075;
RA   Fan X., She Y.-M., Bagshaw R.D., Callahan J.W., Schachter H.,
RA   Mahuran D.J.;
RT   "Identification of the hydrophobic glycoproteins of Caenorhabditis
RT   elegans.";
RL   Glycobiology 15:952-964(2005).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=17606640; DOI=10.1101/gad.1534807;
RA   Meighan C.M., Schwarzbauer J.E.;
RT   "Control of C. elegans hermaphrodite gonad size and shape by vab-
RT   3/Pax6-mediated regulation of integrin receptors.";
RL   Genes Dev. 21:1615-1620(2007).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-108; ASN-228; ASN-608;
RP   ASN-679 AND ASN-819, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Integrin that may have a role in cell motility and in
CC       cell-cell interactions. Required for distal tip cell migration and
CC       dorsal pathfinding (PubMed:17606640). Involved in pat-4
CC       polarization and recruitment to nascent muscle attachment
CC       (PubMed:12015115). {ECO:0000269|PubMed:12015115,
CC       ECO:0000269|PubMed:17606640}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha pat-2
CC       associates with beta pat-3.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in body-wall muscle cells, distal
CC       tip cells, and vulval tissue. {ECO:0000269|PubMed:17606640}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated during L3 developmental stage in
CC       distal tip cells. {ECO:0000269|PubMed:17606640}.
CC   -!- DISRUPTION PHENOTYPE: Severe paralysis, defects in distal tip cell
CC       migration and gonad morphology, defects in egg-laying and
CC       embryonic hatching within the mother (the bag of worms phenotype).
CC       {ECO:0000269|PubMed:12915588, ECO:0000269|PubMed:8106547}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 7 FG-GAP repeats. {ECO:0000305}.
DR   EMBL; FO081385; CCD71234.1; -; Genomic_DNA.
DR   PIR; S44824; S44824.
DR   RefSeq; NP_498948.1; NM_066547.3.
DR   UniGene; Cel.10427; -.
DR   ProteinModelPortal; P34446; -.
DR   SMR; P34446; 26-900.
DR   BioGrid; 41442; 2.
DR   STRING; 6239.F54F2.1; -.
DR   PaxDb; P34446; -.
DR   PRIDE; P34446; -.
DR   EnsemblMetazoa; F54F2.1; F54F2.1; WBGene00003929.
DR   GeneID; 176240; -.
DR   KEGG; cel:CELE_F54F2.1; -.
DR   UCSC; F54F2.1; c. elegans.
DR   CTD; 176240; -.
DR   WormBase; F54F2.1; CE00194; WBGene00003929; pat-2.
DR   eggNOG; NOG26407; -.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000115457; -.
DR   InParanoid; P34446; -.
DR   OMA; EDSHESQ; -.
DR   OrthoDB; EOG71ZP14; -.
DR   PhylomeDB; P34446; -.
DR   Reactome; R-CEL-216083; Integrin cell surface interactions.
DR   Reactome; R-CEL-3000157; Laminin interactions.
DR   Reactome; R-CEL-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-CEL-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-CEL-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-CEL-445144; Signal transduction by L1.
DR   SignaLink; P34446; -.
DR   NextBio; 891720; -.
DR   PRO; PR:P34446; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   GO; GO:0009986; C:cell surface; IDA:WormBase.
DR   GO; GO:0008305; C:integrin complex; ISS:WormBase.
DR   GO; GO:0031430; C:M band; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:WormBase.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:1901076; P:positive regulation of engulfment of apoptotic cell; IMP:WormBase.
DR   GO; GO:0040017; P:positive regulation of locomotion; IMP:WormBase.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Complete proteome; Glycoprotein; Integrin; Membrane;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   1226       Integrin alpha pat-2.
FT                                /FTId=PRO_0000016332.
FT   TOPO_DOM     26   1154       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1155   1177       Helical. {ECO:0000255}.
FT   TOPO_DOM   1178   1226       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       27     94       FG-GAP 1.
FT   REPEAT      108    171       FG-GAP 2.
FT   REPEAT      178    233       FG-GAP 3.
FT   REPEAT      234    290       FG-GAP 4.
FT   REPEAT      291    345       FG-GAP 5.
FT   REPEAT      362    421       FG-GAP 6.
FT   REPEAT      425    488       FG-GAP 7.
FT   MOTIF       620    622       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    228    228       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    290    290       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:15888633}.
FT   CARBOHYD    608    608       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    679    679       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    775    775       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    819    819       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
**
**   #################    INTERNAL SECTION    ##################
**EV ECO:0000250; -; XXX; 01-JAN-1900.
**EV ECO:0000255; -; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:12015115; ROZ; 15-JUL-2015.
**EV ECO:0000269; PubMed:12915588; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:15888633; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:17606640; ROZ; 15-JUL-2015.
**EV ECO:0000269; PubMed:17761667; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:8106547; XXX; 01-JAN-1900.
**EV ECO:0000305; -; XXX; 01-JAN-1900.
**ZB ALG/LYG, 28-OCT-2006; LYG, 30-APR-2008; DJL, 20-MAR-2009; ROZ, 17-JUL-2015;
SQ   SEQUENCE   1226 AA;  135940 MW;  B9169AD75B88901D CRC64;
     MREGSFPRRI GLLLGLLGLL AGVATFNIDT KNVVVHHMAG NYFGYSLDFY HEQKGMPVLV
     VGAPEAESNN PNLAGIRRPG AVYACSVNRA TCREVHVDKM KGNLKKLNGS HLVPIEEKSH
     QFFGATVRSN DKHDKIVVCA PKYTYFYSKF EVIEPVGTCF YAENGFDNAE EFSSCKQEPA
     RHGRHRLGYG QCGFSAAVPG KKNQNRVFIG APGVWYWQGA MFSQNIKNQT DRPNTEYGSK
     EYDHDMMGYS TATGDFDGDG IDDIVAGVPR GNDLHGKLVL YTSKLKMMIN LTDEVSTQHG
     QYCGGSVAVA DVNKDGRDDI IMGCPFYTDY GSVKDAKTQE RKPQYDVGKV IVMLQTAPGV
     FGKQIAVVGD DQWGRFGHAV AAAGDLNLDG YNDVIVGAPY AGKNKQGAVY VIHGSKDGVR
     ELPTQKIEGA NIGHGNIKSF GFSLTGNEDV DGNGMPDIAV GAWKSGNAAV LLTKPVVTVT
     GQTEPESALI SVEDKNCDVD GKLGKQACKH INTCFKYEGK GDTPNDLEFD LRFNLDDHSP
     EPRAYFLQKD VKSDRSIKVA QGSKTRDHPS SIEQRVRLEK GRQKCFRHRF FASSTMKDKL
     SPIHWSVNYT YVESKTGKLR GDKLEPAIDT TVPLSFQNKI NIANNCGKDD LCVPDLKVTA
     VADREKFLLG TQDNTMLINV TVQNGGEDSY ETKLYFDVPQ GFEYGGIESV GGDGSKSAPA
     CSPTSDEPDS DGKWTFACDL GNPLPANKVV SSVVRVTASS DKPPLAPISI NAHVNSSNDE
     EAHTVADNKV TFTIPVDFKN QLSLNGRSNP EQVDFSMTNK TRVDAFDDNE IGPVVSHLYQ
     ISNRGPSEVD SATLDIFWPS FSTEGGHLLY IITEPVVNPP NKGRCRVKQL QNVNPLNLRI
     TNEHVPTEPP VAKTPNEYSR EEDDESYEDE TTTQSQSTRH QSTQHQTHHQ SGPVHVYEKD
     EEKIRQNTGN WQYVEDKKKK GDYEYIPDDQ EYDGDDFEEE DDEDFDRAGS KRVKRNPTPK
     KKKKGGEHRG EPRSDKARFS DLREAVKLSK EAGGVVDYKG PLSRASVDCN SLRCTHIECD
     IYDLKEDEFV LVEIFSRLYT NTLVDEKNPG GDISSLALAR VTSTKYNLPH KPTLITAVST
     NMNAIASEEG RDLPWWLYLL AILIGLAILI LLILLLWRCG FFKRNRPPTE HAELRADRQP
     NAQYADSQSR YTSQDQYNQG RHGQML
//
ID   JD1_AMOJI               Unreviewed;        63 AA.
AC   K7ZGS2;
DT   06-FEB-2013, integrated into UniProtKB/TrEMBL.
DT   06-FEB-2013, sequence version 1.
DT   04-FEB-2015, entry version 9.
DE   RecName: Full=Jingdongin-1 {ECO:0000303|PubMed:22828809};
DE   Flags: Precursor;
OS   Amolops jingdongensis (Chinese torrent frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Neobatrachia; Ranoidea; Ranidae; Amolops.
OX   NCBI_TaxID=1077530 {ECO:0000312|EMBL:AFY06638.1};
RN   [1] {ECO:0000312|EMBL:AFY06638.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 47-63, FUNCTION,
RP   SUBCELLULAR LOCATION, AND MASS SPECTROMETRY.
RX   PubMed=22828809; DOI=10.1007/s00726-012-1358-z;
RA   He X., Yang S., Wei L., Liu R., Lai R., Rong M.;
RT   "Antimicrobial peptide diversity in the skin of the torrent frog,
RT   Amolops jingdongensis.";
RL   Amino Acids 44:481-487(2013).
CC   -!- FUNCTION: The synthetic peptide has antimicrobial activity against
CC       Gram-negative bacterium B.dysenteriae (MIC=35 ug/ml), against
CC       Gram-positive bacteria S.aureus ATCC 2592 (MIC=4.7 ug/ml) and
CC       B.subtitlis ATCC 6633 (MIC=9.38 ug/ml) and against fungus
CC       C.albicans (MIC=18.75 ug/ml). Has no activity against Gram-
CC       negative bacterium E.coli ATCC 25922 but exhibits low hemolytic
CC       activity at concentrations up to 200 ug/ml.
CC       {ECO:0000269|PubMed:22828809}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000255|SAAS:SAAS00090082,
CC       ECO:0000269|PubMed:22828809}.
CC   -!- TISSUE SPECIFICITY: Expressed by the skin glands.
CC       {ECO:0000305|PubMed:22828809}.
CC   -!- MASS SPECTROMETRY: Mass=1974.6; Method=MALDI; Range=47-63;
CC       Evidence={ECO:0000269|PubMed:22828809};
CC   -!- SIMILARITY: Belongs to the frog skin active peptide (FSAP) family.
CC       Brevinin subfamily. {ECO:0000305}.
DR   EMBL; JQ681300; AFY06638.1; -; mRNA.
DR   TCDB; 1.C.52.1.32; the dermaseptin (dermaseptin) family.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:InterPro.
DR   InterPro; IPR004275; Brevinin.
DR   Pfam; PF03032; Brevenin; 1.
PE   2: Evidence at transcript level;
KW   Amphibian defense peptide; Antibiotic; Antimicrobial;
KW   Cleavage on pair of basic residues; Cytolysis;
KW   Direct protein sequencing; Hemolysis; Secreted; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   PROPEP       23     44       {ECO:0000305}.
FT   PEPTIDE      47     63       Jingdongin-1.
FT                                {ECO:0000269|PubMed:22828809}.
**
**   #################    INTERNAL SECTION    ##################
**   PROSITE; PS00387; PPASE; 1; FALSE_POS.
**EV ECO:0000255; -; KLP; 04-JUN-2015.
**EV ECO:0000255; SAAS:SAAS00090082; KLP; 04-JUN-2015.
**EV ECO:0000269; PubMed:22828809; KLP; 04-JUN-2015.
**EV ECO:0000303; PubMed:22828809; KLP; 23-OCT-2014.
**EV ECO:0000305; -; KLP; 04-JUN-2015.
**EV ECO:0000305; PubMed:22828809; KLP; 23-OCT-2014.
**EV ECO:0000312; EMBL:AFY06638.1; KLP; 04-JUN-2015.
**SO UPD; 95199; 14-OCT-2014.
**ZA KLP, 04-JUN-2015;
**ZZ Other sequences characterized in PMID:22828809 will follow shortly.
**ZZ The update request was only for this entry and is long overdue.
SQ   SEQUENCE   63 AA;  7464 MW;  CF9E4E7605A4766E CRC64;
     MLTLKKSMLL LFFLGTINLS LCEQERDADE EERRDDDEMD VEVEKRFLPL FLPKIICVIT
     KKC
//
